Nationally Renowned Organization and Doctor Discuss the Newly-Ranked Allergy-Suffering Areas and Tips to Cope This Season
More than 50 million Americans suffer from allergies each year and while the seasonal allergy symptoms appear not to discriminate by age or gender, where one lives could be a main factor in the volume and strength of suffering. On March 23rd, the Asthma and Allergy Foundation of America (AAFA) will release its annual Spring Allergy Capitals™ report ranking the 100 most challenging places to live with spring allergies in the U.S.
Here is an inside-look into this year’s chosen areas with leading allergy specialist, Dr. Purvi Parikh and Dr. Cary Sennett at the Asthma and Allergy Foundation of America (AAFA). Together they will speak to the newest capitals and tips for coping with spring allergy symptoms in these areas and beyond. 2016’s report provides some interesting results and an interview is sure to be fun and educational for your viewers/listeners.
Dr. Parikh and Dr. Sennett discuss:
- The process behind choosing the allergy capitals each year
- Surprise cities and repeat areas for 2016
- Steps allergy-sufferers can take and questions to ask your physician
- Doctor-recommended treatment options
About Dr. Purvi Parikh: Dr. Parikh is an adult and pediatric allergist and immunologist serving patients in and around the Murray Hill area of New York, providing state-of-the-art care in a comfortable, relaxing environment. She offers a comprehensive array of diagnostic and treatment procedures to identify and manage immune system-related conditions, including food and drug allergies, asthma, chronic sinusitis and immune deficiency diseases.
Double-board certified by the American Board of Allergy and Immunology and the American Board of Internal Medicine, Dr. Parikh is dedicated to learning new techniques that can provide her patients with safer, more effective, individualized care so they can experience the best health possible at every age.
About Dr. Cary Sennett: Dr. Cary Sennett, President and CEO at the Asthma and Allergy Foundation of America, has more than 25 years of experience working with both public and private sector organizations to make the health care system work better for patients. After several years of working in managed care, he played a leadership role as Executive Vice President at the National Committee for Quality Assurance (NCQA) where he helped to build-out the HEDIS® national standard measurement set used to evaluate the quality of care and service offered by managed care organizations in markets across the country. That work has been the foundation of consumer and patient “report cards” on healthcare quality and innovative programs that reward health plans for delivering higher quality care. In the years since his work at NCQA, Dr. Sennett has worked with physician organizations and, more recently, in the policy world to use incentives to promote higher quality and more patient centered care.
About the Asthma and Allergy Foundation of America (AAFA): Founded in 1953 and celebrating over 60 years of service, the Asthma and Allergy Foundation of America (AAFA) is the oldest and largest nonprofit patient organization dedicated to improving the quality of life for people with asthma, allergies and related conditions through education, advocacy and research. AAFA provides practical information, community-based services, support and referrals through a national network of chapters and educational support groups. For more information, visit www.aafa.org.
About Meda Pharmaceuticals: Meda is a leading international specialty pharma company with a broad product portfolio and its own sales organizations in almost 60 countries. Including those markets where sales are managed by distributors, Meda’s products are sold in more than 120 different countries. Meda’s product portfolio is divided into three main areas: specialty products, OTCs (nonprescription products and dietary supplements) and branded generics. In the United States, Meda has a strong history in respiratory innovation, with a focus in allergy and asthma.
*Interview courtesy of Meda Pharmaceuticals
